Clinical Trial Update: A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating platelet-rich plasma to treat Vulvar Lichen Sclerosus is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvar Lichen Sclerosus

Drugs mentioned

• Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Jennifer R. Arthurs | Conditions: Vulvar Lichen Sclerosus | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING